for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Hapvida Participacoes e Investimentos SA

HAPV3.SA

Latest Trade

51.72BRL

Change

0.23(+0.45%)

Volume

1,667,600

Today's Range

50.80

 - 

52.17

52 Week Range

21.04

 - 

52.86

As of on the Bolsa de Valores do Estado de Sao Paulo ∙ Minimum 15 minute delay

Pricing

Previous Close
51.49
Open
51.50
Volume
1,667,600
3M AVG Volume
45.17
Today's High
52.17
Today's Low
50.80
52 Week High
52.86
52 Week Low
21.04
Shares Out (MIL)
734.65
Market Cap (MIL)
37,827.26
Forward P/E
42.91
Dividend (Yield %)
0.62

Latest Developments

More

Brazilian Healthcare Provider Hapvida Buys Smaller Rival RN Saude For 53 Million Reais- Filing

Hapvida CEO Says Co Still Searching For New Acquisitions In The Short Term

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Hapvida Participacoes e Investimentos SA

Hapvida Participacoes e Investimentos SA (Hapvida) is a Brazil-based holding healthcare company. The Company and its subsidiaries main activities are the coverage of costs of medical, hospital and dental care of its associates, the provision of medical, hospital and dentistry services and examinations and diagnoses per image. Hapvida has different healthcare facilities such as hospitals, clinics or diagnostic imaging units. The Company operates in the Northeast of Brazil, in more than 10 states such as Alagoas, Amazonas, Bahia, Pernambuco, Rio Grande do Norte, Sergipe, among others.

Industry

Healthcare Facilities

Contact Info

Av Heraclito Graca 406, Centro

+55.85.40023633

Key Stats

2.00 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, BRL)

2018

4.6K

2019(E)

5.6K
EPS (BRL)

2018

1.240

2019(E)

1.200
Price To Earnings (TTM)
39.85
Price To Sales (TTM)
7.71
Price To Book (MRQ)
8.85
Price To Cash Flow (TTM)
40.34
Total Debt To Equity (MRQ)
22.08
LT Debt To Equity (MRQ)
21.29
Return on Investment (TTM)
19.58
Return on Equity (TTM)
15.34

Latest News

Brazil's Hapvida board approves $628 million capital raise

Brazilian healthcare provider Hapvida Participações e Investimentos SA said in a securities filing early on Thursday its administration board approved the terms of a share offering to raise 2.368 billion reais ($627.68 million).

Brazil's healthcare firm Hapvida launches $700 mln share offering - filing

Brazilian healthcare company Hapvida Participacoes e Investimentos SA <HAPV3.SA> launched a share offering that may raise up to 2.63 billion reais ($704 million), according to a securities filing on Friday.

Brazil's Hapvida to acquire smaller rival America Group -filing

Brazilian healthcare provider Hapvida Participacoes e Investimentos SA has reached an agreement to acquire smaller rival America Group for 426 million reais ($109.87 million), according to a securities filing on Sunday.

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 2030 GMT on Wednesday:

Brazil healthcare firm Hapvida looking for more acquisitions: CEO

Brazilian healthcare provider Hapvida Participacoes e Investimentos SA will look for more acquisitions in the near future after agreeing to acquire rival group Sao Francisco Saude for 5 billion reais ($1.26 billion), Chief Executive Officer Jorge Pinheiro told reporters...

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 20:00 GMT on Tuesday:

Brazil healthcare firm Hapvida to buy rival São Francisco for $1.26 bln -source

Brazilian healthcare company Hapvida Participacoes e Investimentos SA has reached an agreement to acquire rival group São Francisco Saúde for 5 billion reais ($1.26 billion), a source with knowledge of the matter said.

UPDATE 1-Brazil shoemaker Dass cancels IPO on weak demand -source

Brazilian shoemaker Dass Nordeste Calçados e Artigos Esportivos SA has decided to cancel its initial public offering because of weak demand, according to a source familiar with the matter.

Brazilian shoemaker Dass may cancel IPO on weak demand -source

Brazilian shoemaker Dass Nordeste Calçados e Artigos Esportivos SA may cancel its initial public offering because of weak demand, according to a source familiar with the matter.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up